TLRY logo

Tilray Brands, Inc. (TLRY)

Profile

Full Name

Tilray Brands, Inc.

Ticker

NASDAQ: TLRY

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

Canada

IPO

July 19, 2018

Indexes

Not included

Website

http://www.tilray.com

Employees

2650

Key Details

Price

$0.69(-1.43%)

Market cap

$709.67M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$788.94M(+25.80% YoY)

Annual EPS

-$0.33(+85.96% YoY)

PE ratio

-

Next earnings date

Jul 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.69
    TLRY price is $0.69

    30-Day Relative Volume

    1.02
    TLRY 30-day relative volume is 1.02

    Price Performance

    Price Most recent change

    -1.43%
    TLRY price was down -1.43% on Jul 25, 2025

    Price YTD change

    -48.12%
    TLRY price is down -48.12% since January 1st

    Price 1-year change

    -61.24%
    TLRY price is down -61.24% year-on-year

    Price 3-year change

    -80.51%
    TLRY price is down -80.51% over the past 3 years

    Price Range

    Price All-time high

    $300.00
    TLRY price is currently -99.77% below its historical high of $300.00

    Price 3-year low

    $0.35
    TLRY price is currently +97.14% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $709.67M
    TLRY market capitalization is $709.67 million

    Market cap 3-year change

    -62.63%
    TLRY market capitalization is down -62.63% over the past 3 years

    Market cap All-time high

    $41.73B
    TLRY market capitalization is currently -98.30% below its historical high of $41.73 billion

    Market cap sector rank

    69.83%
    TLRY market capitalization is higher than 69.83% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +22.01%
    TLRY shares outstanding is up +22.01% year-on-year

    Shares Outstanding 3-Year Change

    +91.75%
    TLRY shares outstanding is up +91.75% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.48
    TLRY beta is 1.48

    200-day SMA

    $0.91
    TLRY price is currently -24.14% below its 200-day simple moving average

    50-day SMA

    $0.49
    TLRY price is currently +40.93% above its 50-day simple moving average

    RSI

    60.56
    TLRY 14-day relative strength index is 60.56

    Volume

    1.02
    TLRY 30-day relative volume is 1.02

    ATR

    $0.06
    TLRY average true range is $0.06

    10-day Historical Volatility

    142.40%
    TLRY 10-day historical volatility is 142.40%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $788.94M
    TLRY annual revenue is $788.94 million

    Revenue Analysts estimate

    $835.52M
    TLRY annual revenue is currently -5.57% lower than the consensus analysts' forecast

    Revenue 1-year change

    +25.8%
    TLRY annual revenue is up +25.8% year-on-year

    Revenue Sector rank

    78.4%
    TLRY annual revenue is higher than 78.4% of companies in Healthcare sector

    EPS

    EPS

    -$0.33
    TLRY annual earnings per share is -$0.33

    EPS Analysts estimate

    -$0.02
    TLRY annual earnings per share is currently +1550.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +85.96%
    TLRY annual earnings per share is up +85.96% year-on-year

    EPS Sector rank

    71.78%
    TLRY annual earnings per share is higher than 71.78% of companies in Healthcare sector

    Profit

    Gross profit

    $223.35M
    TLRY annual gross profit is $223.35 million

    Gross margin

    28.31%
    TLRY annual gross profit margin is 28.31%

    Operating profit

    -$112.76M
    TLRY annual operating income is -$112.76 million

    Operating margin

    -14.29%
    TLRY annual operating profit margin is -14.29%

    Net income

    -$244.98M
    TLRY annual net profit is -$244.98 million

    Net margin

    -31.05%
    TLRY annual net profit margin is -31.05%

    Expenses

    Total expenses

    $901.70M
    TLRY annual total expenses is $901.70 million

    Operating expenses

    $336.11M
    TLRY annual total operating expenses is $336.11 million

    Cost of goods sold

    $565.59M
    TLRY annual cost of goods sold is $565.59 million

    Selling, general & administrative expenses

    $250.72M
    TLRY annual SGA is $250.72 million

    Depreciation and amortization

    $126.91M
    TLRY annual depreciation & amortization is $126.91 million

    Interest expense

    $49.26M
    TLRY annual interest expense is $49.26 million

    Income tax

    -$26.62M
    TLRY annual income tax is -$26.62 million

    EBIT & EBITDA

    EBIT

    -$199.76M
    TLRY annual earnings before interest & taxes is -$199.76 million

    EBITDA

    -$72.84M
    TLRY annual EBITDA is -$72.84 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.22B
    TLRY annual total assets is $4.22 billion

    Non current assets

    $3.54B
    TLRY annual long term assets is $3.54 billion

    Current assets

    $677.71M
    TLRY annual total current assets is $677.71 million

    Cash and cash equivalents

    $228.34M
    TLRY annual cash & cash equivalents is $228.34 million

    Accounts receivable

    $101.69M
    TLRY annual accounts receivable is $101.69 million

    Inventory

    $252.09M
    TLRY annual inventory is $252.09 million

    Liabilities

    Total liabilities

    $778.49M
    TLRY annual total liabilities is $778.49 million

    Long term liabilities

    $479.32M
    TLRY annual total long term liabilities is $479.32 million

    Current liabilities

    $299.17M
    TLRY annual total current liabilities is $299.17 million

    Accounts payable

    $105.39M
    TLRY annual accounts payable is $105.39 million

    Debt

    Total debt

    $387.32M
    TLRY annual total debt is $387.32 million

    Total debt 1-year change

    -34.37%
    TLRY annual total debt is down -34.37% year-on-year

    Long term debt

    $348.36M
    TLRY annual long term debt is $348.36 million

    Short term debt

    $38.96M
    TLRY annual short term debt is $38.96 million

    Equity & Capital

    Shareholders equity

    $3.44B
    TLRY annual stockholders equity is $3.44 billion

    Book value

    $3.44B
    TLRY annual book value is $3.44 billion

    Retained earnings

    -$2.66B
    TLRY annual retained earnings is -$2.66 billion

    Working capital

    $378.54M
    TLRY annual working capital is $378.54 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$30.91M
    TLRY annual cash flow from operations is -$30.91 million

    Cash from operations 1-year change

    -490.91%
    TLRY annual cash flow from operations is down -490.91% year-on-year

    Cash from investing

    $128.35M
    TLRY annual cash flow from investing activities is $128.35 million

    Cash from investing 1-year change

    +145.02%
    TLRY annual cash flow from investing activities is up +145.02% year-on-year

    Cash from financing

    -$75.19M
    TLRY annual cash flow from financing activities is -$75.19 million

    Cash from financing 1-year change

    -207.17%
    TLRY annual cash flow from financing activities is down -207.17% year-on-year

    CAPEX

    CAPEX

    $29.25M
    TLRY annual capital expenditures is $29.25 million

    CAPEX 1-year change

    +40.62%
    TLRY annual capital expenditures is up +40.62% year-on-year

    Free Cash Flow

    Free cash flow

    -$60.15M
    TLRY annual free cash flow is -$60.15 million

    Free cash flow 1-year change

    -366.53%
    TLRY annual free cash flow is down -366.53% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    28.31%
    TLRY annual gross profit margin is 28.31%

    Operating margin

    -14.29%
    TLRY annual operating profit margin is -14.29%

    Net margin

    -31.05%
    TLRY annual net profit margin is -31.05%

    ROA & ROE

    ROA

    -5.74%
    TLRY annual return on assets is -5.74%

    ROE

    -7.23%
    TLRY annual return on equity is -7.23%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TLRY price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TLRY price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.26
    TLRY price to book ratio is 0.26

    PB ratio Sector rank

    19.69%
    TLRY price to book ratio is higher than 19.69% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.86
    TLRY price to sales ratio is 0.86

    PS ratio Sector rank

    21.2%
    TLRY price to sales ratio is higher than 21.2% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $853.62M
    TLRY enterprise value is $853.62 million

    Enterprise value Sector rank

    72.39%
    TLRY enterprise value is higher than 72.39% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.10
    TLRY EV/EBITDA is -1.10

    EV/EBITDA Sector rank

    48.86%
    TLRY EV/EBITDA is higher than 48.86% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.27
    TLRY annual current ratio is 2.27

    Quick ratio

    1.42
    TLRY annual quick ratio is 1.42

    Leverage

    Debt to equity

    0.09
    TLRY annual debt to equity ratio is 0.09

    Interest coverage ratio

    -4.05
    TLRY annual interest coverage ratio is -4.05

    Risk & Stability

    Piotroski F-Score

    5
    TLRY piotroski f-score is 5

    Altman Z-Score

    -0.20
    TLRY altman z-score is -0.20

    Analyst ratings

    Recent major analysts updates

    Apr 9, 25 Piper Sandler
    Neutral
    Oct 11, 24 Roth MKM
    Neutral
    Jun 27, 24 Zuanic & Associates
    Neutral
    Apr 10, 24 CIBC
    Neutral
    Sep 1, 23 Roth MKM
    Neutral
    Apr 11, 23 TD Cowen
    Outperform
    Jan 10, 23 Alliance Global Partners
    Neutral
    Nov 2, 22 Bernstein
    Market Perform
    Oct 10, 22 Cantor Fitzgerald
    Neutral
    Sep 30, 22 Barclays
    Underweight

    Institutional Ownership

    Screeners with TLRY included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks below analysts price target
    • What is the ticker symbol for Tilray Brands, Inc.?
    • Does Tilray Brands, Inc. pay dividends?
    • What sector is Tilray Brands, Inc. in?
    • What industry is Tilray Brands, Inc. in?
    • What country is Tilray Brands, Inc. based in?
    • When did Tilray Brands, Inc. go public?
    • Is Tilray Brands, Inc. in the S&P 500?
    • Is Tilray Brands, Inc. in the NASDAQ 100?
    • Is Tilray Brands, Inc. in the Dow Jones?
    • When was Tilray Brands, Inc.'s last earnings report?
    • When does Tilray Brands, Inc. report earnings?

    What is the ticker symbol for Tilray Brands, Inc.?

    The ticker symbol for Tilray Brands, Inc. is NASDAQ:TLRY

    Does Tilray Brands, Inc. pay dividends?

    No, Tilray Brands, Inc. does not pay dividends

    What sector is Tilray Brands, Inc. in?

    Tilray Brands, Inc. is in the Healthcare sector

    What industry is Tilray Brands, Inc. in?

    Tilray Brands, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Tilray Brands, Inc. based in?

    Tilray Brands, Inc. is headquartered in Canada

    When did Tilray Brands, Inc. go public?

    Tilray Brands, Inc.'s initial public offering (IPO) was on July 19, 2018

    Is Tilray Brands, Inc. in the S&P 500?

    No, Tilray Brands, Inc. is not included in the S&P 500 index

    Is Tilray Brands, Inc. in the NASDAQ 100?

    No, Tilray Brands, Inc. is not included in the NASDAQ 100 index

    Is Tilray Brands, Inc. in the Dow Jones?

    No, Tilray Brands, Inc. is not included in the Dow Jones index

    When was Tilray Brands, Inc.'s last earnings report?

    Tilray Brands, Inc.'s most recent earnings report was on April 8, 2025

    When does Tilray Brands, Inc. report earnings?

    The next expected earnings date for Tilray Brands, Inc. is July 28, 2025
    On this page